Please login to the form below
Jeremy Sayers
This page shows the latest Jeremy Sayers news and features for those working in and with pharma, biotech and healthcare.
The behavioural science of adherence
A broad range of factors can influence a person’s decision not to take treatment as prescribed but these can now be seen to be underpinned by academic principles
Latest news
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
New truths and realities in these strange times
By Jeremy Sayers. Most of us are finding the COVID-19 world different and challenging.However, many of us are also finding that this novel situation gives us the opportunity for ... In association with. Jeremy Sayers is Managing Director of Origins
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Bedrock Group bolsters team with three key appointments
Vicky brings to Origins Insights the ability to apply our unique methodology to a widening range of customers across the drug development lifecycle,” said Jeremy Sayers, managing director of Origins Insights.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Bedrock Group celebrates a trio of new hires
Jeremy Sayers, Managing Director of Origins Insights says “As Origins Insights grows, our expert team of qualitative researchers and strategists grows.
-
Bedrock Group strengthens its senior team
Having formed Origins in January this year, the health experience research business led by my colleague Jeremy Sayers, the Bedrock group is poised for growth.
-
Bedrock Group announces the launch of Origins, a health experience research company
With a mission of unearthing and understanding real world health experiences, the new company will be led by Jeremy Sayers. ... audience. Jeremy stated, “I’m truly excited to be leading the team that will take Bedrock Group’s experiential research
More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
- Medscape Oncology’s Large Presence at ASH 2023
No results were found
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
